169 related articles for article (PubMed ID: 10923083)
1. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder.
Duval JV; Savas L; Banner BF
Arch Pathol Lab Med; 2000 Aug; 124(8):1196-200. PubMed ID: 10923083
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract.
Cabibi D; Licata A; Barresi E; Craxì A; Aragona F
Pathol Res Pract; 2003; 199(2):65-70. PubMed ID: 12747467
[TBL] [Abstract][Full Text] [Related]
3. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.
Rullier A; Le Bail B; Fawaz R; Blanc JF; Saric J; Bioulac-Sage P
Am J Surg Pathol; 2000 Jun; 24(6):870-6. PubMed ID: 10843291
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
Tot T
Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990
[TBL] [Abstract][Full Text] [Related]
6. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis.
Tot T; Samii S
APMIS; 2003 Dec; 111(12):1075-82. PubMed ID: 14678015
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
8. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
[TBL] [Abstract][Full Text] [Related]
9. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
Park SY; Kim HS; Hong EK; Kim WH
Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis.
Jiang J; Ulbright TM; Younger C; Sanchez K; Bostwick DG; Koch MO; Eble JN; Cheng L
Arch Pathol Lab Med; 2001 Jul; 125(7):921-3. PubMed ID: 11419977
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
Zhou H; Schaefer N; Wolff M; Fischer HP
Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
[TBL] [Abstract][Full Text] [Related]
12. Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study.
Henson DE; Schwartz AM; Nsouli H; Albores-Saavedra J
Arch Pathol Lab Med; 2009 Jan; 133(1):67-71. PubMed ID: 19123739
[TBL] [Abstract][Full Text] [Related]
13. [Cytokeratins 7 and 20 immunohistochemistry in ampullary carcinomas].
Le Pessot F; Ranty ML; Hellot MF; Lemoine F; Ténière P; Testart J; Métayer J
Ann Pathol; 2004 Sep; 24(4):312-8. PubMed ID: 15567946
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
Bayrak R; Yenidünya S; Haltas H
Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
[TBL] [Abstract][Full Text] [Related]
15. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
Tot T
Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
[TBL] [Abstract][Full Text] [Related]
16. Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract.
Sung JY; Kim GY; Lim SJ; Park YK; Kim YW
Pathol Res Pract; 2010 Jan; 206(1):24-9. PubMed ID: 19819644
[TBL] [Abstract][Full Text] [Related]
17. Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases.
Tot T
Ann Diagn Pathol; 1999 Dec; 3(6):350-6. PubMed ID: 10594286
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.
Goldstein NS; Bassi D
Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 7 and 20 expression in gallbladder carcinoma.
Kalekou H; Miliaras D
Pol J Pathol; 2011; 62(1):25-30. PubMed ID: 21574103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
